Microbix Biosystems, Inc.

Microbix Biosystems, Inc. — FDA 510(k) Submissions

Microbix Biosystems, Inc. has submitted 7 FDA 510(k) premarket notifications since 1985, of which 7 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Antigens, Cf, All, Mycoplasma Spp., Antigens, Cf, Toxoplasma Gondii, Antigen, Cf (including Cf Control), Rubella, Antiserum, Cf, Cytomegalovirus, Antiserum, Cf, Varicella-zoster . Use the specialty filter in the sidebar to narrow results.